Search - tctmd.com

Displaying 61 - 80 of 82

Sort: Relevancy | Date

News Opinion Editor's Corner

TCTMD’s Top 10 Most Popular Stories for June 2022

Caitlin E. Cox

July 04, 2022

News Features

Risking COVID-19 for Professional Gain? Spring’s In-Person Meetings in Hindsight

Yael L. Maxwell

June 16, 2022

News Daily News

COVID-19 Vaccination Tied to Better Outcomes in HF Patients

Todd Neale

June 09, 2022

News Daily News

CVD Hospitalizations Spiked in Aftermath of 2020 US Election

Michael O'Riordan

April 22, 2022

News Daily News

Skipping Low-Value Cardiovascular Care Could Save Billions: AHA

Michael O'Riordan

March 01, 2022

News Daily News

Financial Strain Ups Risk of Death After Acute MI in the Elderly

L.A. McKeown

February 25, 2022

News Daily News

In the US, HF Prevalence—and Costs—Rising Steeply: HFSA Report

Michael O'Riordan

January 27, 2022

News Opinion CV Team Dispatch

December 2021 News Roundup

L.A. McKeown

December 01, 2021

News Opinion Editor's Corner AHA 2021

AHA 2021 Tackles AF Triggers, Watchful Waiting in AS, Data Overload, and More

Shelley Wood

November 08, 2021

News Daily News HFSA 2021

In HF and Diabetes, Mobile Health App Modestly Boosts Physical Activity

Michael O'Riordan

September 15, 2021

News Conference News HFSA 2021

Digital App Improves HF Quality-of-Care Metrics: CONNECT-AF

Michael O'Riordan

September 14, 2021

News Conference News HRS 2021

Catheter Ablation ‘Good Value’ in CABANA Economic Analysis

Michael O'Riordan

August 04, 2021

News Daily News

Belly Fat the Biggest Driver of Obesity-Related CVD, Says AHA

Michael O'Riordan

April 26, 2021

News Opinion CV Team Dispatch

February 2021 News Roundup

L.A. McKeown

February 01, 2021

News Daily News

AHA’s 2020 Top 10: ISCHEMIA, HCM, Early A-fib Intervention, and More

Shelley Wood

December 17, 2020

News Conference News ESC 2020

ACE Inhibitors, ARBs Pose No Risk in COVID-19: BRACE CORONA

Michael O'Riordan

September 01, 2020

News Daily News

New Review Tracks ‘Evolving’ CV Impact of COVID-19 on Patients, Hospitals

Michael O'Riordan

March 20, 2020

News Daily News

COVID-19 Should Not Guide Use of ACE Inhibitors/ARBs, Heart Societies Say

Todd Neale

March 17, 2020

News Features

‘Outrageous’ $225,000 per Year List Price for Tafamidis Draws Outcry

Michael O'Riordan

January 10, 2020

News Daily News

Year in Review: New Guidelines, Inclisiran, Dapagliflozin Impact CVD Prevention in 2019

Yael L. Maxwell

December 20, 2019

Advertisement

TCTMD’s Top 10 Most Popular Stories for June 2022

Risking COVID-19 for Professional Gain? Spring’s In-Person Meetings in Hindsight

COVID-19 Vaccination Tied to Better Outcomes in HF Patients

CVD Hospitalizations Spiked in Aftermath of 2020 US Election

Skipping Low-Value Cardiovascular Care Could Save Billions: AHA

Financial Strain Ups Risk of Death After Acute MI in the Elderly

In the US, HF Prevalence—and Costs—Rising Steeply: HFSA Report

December 2021 News Roundup

AHA 2021 Tackles AF Triggers, Watchful Waiting in AS, Data Overload, and More

In HF and Diabetes, Mobile Health App Modestly Boosts Physical Activity

Digital App Improves HF Quality-of-Care Metrics: CONNECT-AF

Catheter Ablation ‘Good Value’ in CABANA Economic Analysis

Belly Fat the Biggest Driver of Obesity-Related CVD, Says AHA

February 2021 News Roundup

AHA’s 2020 Top 10: ISCHEMIA, HCM, Early A-fib Intervention, and More

ACE Inhibitors, ARBs Pose No Risk in COVID-19: BRACE CORONA

New Review Tracks ‘Evolving’ CV Impact of COVID-19 on Patients, Hospitals

COVID-19 Should Not Guide Use of ACE Inhibitors/ARBs, Heart Societies Say

‘Outrageous’ $225,000 per Year List Price for Tafamidis Draws Outcry

Year in Review: New Guidelines, Inclisiran, Dapagliflozin Impact CVD Prevention in 2019

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content